Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2012
12/05/2012CN102805757A Osmanthus fragrans extract, preparation method and use of Osmanthus fragrans extract, and medical composite for treating melancholia
12/05/2012CN102805745A Iloperidone composition and preparation method thereof
12/05/2012CN102805740A Rivastigmine capsules and preparation method thereof
12/05/2012CN102805728A Propofol fat emulsion injection and preparation method thereof
12/05/2012CN102370663B Application of pig nail in preparation of medicine or health product used for treating postnatal depression
12/05/2012CN102311481B Methyl toonapubesate A and preparation method as well as application thereof
12/05/2012CN102258758B High-content liquid gingerols and preparation method thereof
12/05/2012CN102258552B Method for preparing angelica dahurica decoction pieces
12/05/2012CN102178661B Levo-tetrahydropalmatine transdermal drug delivery preparation
12/05/2012CN102086193B N-substituted alpha-amino acid derivatives and preparation method and application thereof
12/05/2012CN102078474B Nano-dispersible tablet for four-season common cold and preparation method thereof
12/05/2012CN102056609B Pharmaceutical combination
12/05/2012CN102008626B Purified material obtained from sweet potato and application thereof
12/05/2012CN101991561B 3,4-dichlorophenyl-propenoyl-sec-butylamine composition
12/05/2012CN101889010B Isoxazolo-pyridine derivatives
12/05/2012CN101756988B Compound matrine and diversine nano-emulsion preparation and preparation method thereof
12/05/2012CN101711779B Application of Selaginella pulvinata (Hook.et Grev.) Maxim. extract in preparing medicaments for resisting Alzheimer diseases
12/05/2012CN101665489B Dehydrosilybin trialky ether and preparation method and medical application thereof
12/05/2012CN101618036B Novel medicinal application of carboxyl aminotriazole and acceptable salts of the carboxyl aminotriazole
12/05/2012CN101565419B 7 and 20 dehydro-silybin dialky ether and preparation method and medicine use thereof
12/05/2012CN101563079B Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
12/05/2012CN101549083B Chinese materia medica foot bath preserving health essence
12/05/2012CN101535258B Ether derivatives dual modulators of the 5-ht2a and d3 receptors
12/05/2012CN101437510B A pharmaceutical composition useful as acetyl cholinesterase inhibitors
12/05/2012CN101410378B Malonamide derivatives as gamma secretase inhibitors
12/05/2012CN101255131B Heterocyclic derivatives as opioid modulators
12/05/2012CN101087619B Method of treatment or prophylaxis
12/05/2012CN101084204B Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
12/04/2012US8324425 Method for producing bicyclic γ-amino acid derivative
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324278 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
12/04/2012US8324275 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
12/04/2012US8324242 Modulators of ATP-binding cassette transporters
12/04/2012US8324240 Fused amino pyridine as HSP90 inhibitors
12/04/2012US8324220 Pyrimidines useful as modulators of voltage-gated ion channels
12/04/2012US8324214 1,3-dihydro-2H-pyrrolo[3,2-bpyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
12/04/2012US8324190 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
12/04/2012US8324173 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications
12/04/2012US8323651 Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
12/04/2012CA2713025C Kappa selective opioid receptor antagonist
12/04/2012CA2694401C Polycyclic compound
12/04/2012CA2663511C Thiazole pyrazolopyrimidines as crf1 receptor antagonists
12/04/2012CA2626120C Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
12/04/2012CA2622760C Cyclopropyl amines as modulators of the histamine h3 receptor
12/04/2012CA2617363C Use of ivabradine for the manufacture of medications for the treatment of endothelial dysfunction
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2562189C Azacyclosteroid histamine-3 receptor ligands
12/04/2012CA2537748C Use of telmisartan for the prevention of vascular headache
12/04/2012CA2521177C Use of a botulinum neurotoxin to alleviate various disorders
12/04/2012CA2520613C Implantable polymeric device for sustained release of dopamine agonist
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
11/2012
11/29/2012WO2012162635A1 Metabotropic glutamate receptors 5 modulators and methods of use thereof
11/29/2012WO2012162461A1 Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012WO2012162339A1 Use of teriflunomide for reducing occurrence of relapses requiring healthcare resources
11/29/2012WO2012162334A1 Compounds for the reduction of beta-amyloid production
11/29/2012WO2012162330A1 Tricyclic compounds as inhibitors for the production of beta-amyloid
11/29/2012WO2012162254A1 Inhibitors of lrrk2 kinase activity
11/29/2012WO2012162179A1 Tau protease compositions and methods of use
11/29/2012WO2012162124A1 Neuronal progenitor cells and uses
11/29/2012WO2012161938A1 Clozapine immunoassay
11/29/2012WO2012161877A1 Pyridine-and pyrazine derivatives
11/29/2012WO2012161622A2 Incretin hormone secretion stimulators, method for producing and using same
11/29/2012WO2012161527A2 Composition for preventing or treating neurodegenerative diseases, containing sandal tree extracts or fractions thereof as active ingredients
11/29/2012WO2012161519A1 An adult stem cell line introduced with hepatocyte growth factor gene and neurogenic transcription factor gene with basic helix-loop-helix motif and uses thereof
11/29/2012WO2012161368A1 Preparation method of flumazenil labeled with fluorine-18 using diaryl iodonium salt precursor
11/29/2012WO2012161358A1 Pharmaceutical composition for preventing or treating attention deficit hyperactivity disorder (adhd), containing ginkgo leaf extract with enhanced terpenlactone
11/29/2012WO2012161301A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012WO2012161173A1 Substituted amide compound
11/29/2012WO2012160713A1 Learning and memory improver
11/29/2012WO2012160608A1 Autism improving agent and autism improving tea
11/29/2012WO2012160392A1 Morpholino compounds, uses and methods
11/29/2012WO2012160358A1 Cannabinoids for use in the treatment of neuropathic pain
11/29/2012WO2012160337A1 Sulfated oligosaccharides for use in treatment of neurodegenerative diseases
11/29/2012WO2012160333A2 Recombinant yeast
11/29/2012WO2012160187A1 Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
11/29/2012WO2012160186A1 Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
11/29/2012WO2012160130A1 Erk inhibitors for use in treating spinal muscular atrophy
11/29/2012WO2012160006A1 Antagonists of cb1 receptor.
11/29/2012WO2012159662A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
11/29/2012WO2012159456A1 Cdc42 inhibitor and uses thereof
11/29/2012WO2012136534A3 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
11/29/2012WO2012134206A3 Process for the preparation of anhydrous aripiprazole crystal form ii
11/29/2012WO2012129365A4 Myelin regeneration with androgens
11/29/2012WO2012105813A3 Use of icam-1 for prevention or treatment of neurological diseases
11/29/2012WO2012104823A3 Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
11/29/2012US20120302794 Derivatives of venlafaxine and methods of preparing and using the same
11/29/2012US20120302643 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride
11/29/2012US20120302632 Dietary control of arachidonic acid metabolism
11/29/2012US20120302620 Novel pyrone-indole derivatives and process for their preparation
11/29/2012US20120302619 Novel 1-aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
11/29/2012US20120302616 Method of treatment of obsessive compulsive disorder with ondansetron
11/29/2012US20120302615 Method of treatment of cns disorders
11/29/2012US20120302614 Method for improving cerebral circulation or treating a cerebral blood flow disorder
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302604 Modulation of Phospholipase D for the Treatment of the Acute and Chronic Effects of Ethanol
11/29/2012US20120302603 Amyloid binding agents
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302600 Stable laquinimod preparations
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 1833